,,iii #aae? ,,congress #b;d ,session ,s4 ,,res4 #eca ,,9 ,,! ,,s5ate ,,( ,,! ,,unit$ ,,/ates ,may #bd1 #bjah,mr4 ,da9es 7= himself1 ,mr4 ,m>key1 ,ms4 ,coll9s1 & ,mr4 ,van ,holl57 submitt$ ! foll[+ resolution2 :i* 0 consid]$ & agre$ to ,,resolution ,express+ support = ! designation ( ,may #bjah z ,national ,bra9 ,tumor ,aw>5ess ,mon?4 ,:]eas an e/imat$ #gh1ihj new cases ( prim>y & non-malignant tumors 9 ! bra9 & c5tral n]v\s sy/em are expect$ to be diagnos$ 9 ! ,unit$ ,/ates dur+ cal5d> ye> #bjah2 ,:]eas up to #ejj1jjj individuals 7 diagnos$ ) meta/atic bra9 tumors t 7 ! result ( canc] spread+ f ano!r "p ( ! body to ! bra9 9 #bjaf2 ,:]eas p$iatric bra9 tumors are ! lead+ cause ( dea? f canc] 9 *ildr5 "u ! age ( #ai2 ,:]eas ! av]age survival rate 9 ! ,unit$ ,/ates = all malignant bra9 tumor pati5ts is only #cd4i p]c5t2 ,:]eas an e/imat$ #af1faf p 9 ! ,unit$ ,/ates w lose _! battle ) a prim>y bra9 tumor dur+ cal5d> ye> #bjah2 ,:]eas bra9 tumors may be malignant or b5ign1 b c be life-?reat5+ 9 ei!r case2 ,:]eas ne>ly #gjj1jjj p 9 ! ,unit$ ,/ates are curr5tly liv+ ) a bra9 tumor2 ,:]eas treatm5t ( bra9 tumors is complicat$ by ! fact t !re are m ?an #acj diff]5t types ( tumors2 ,:]eas ! treatm5t & removal ( bra9 tumors pres5t significant *all5ges because ( ! uniquely complex & fragile nature ( ! bra92 ,:]eas bra9 tumors affect ! prim>y organ 9 ! human body t n only controls cognitive ability1 b ! actions ( e o!r organ & limb 9 ! body1 lead+ to bra9 tumors be+ describ$ z a disease t affects ! :ole individual2 ,:]eas bra9 tumor rese>* is support$ by a numb] ( private1 nonpr(it rese>* f\ndations1 & by in/itutes at ! ,national ,in/itutes ( ,heal?1 includ+ ! ,national ,canc] ,in/itute & ! ,national ,in/itute = ,neurological ,disord]s & ,/roke2 ,:]eas basic rese>* advances may fuel rese>* & developm5t ( new treatm5ts = bra9 tumors2 ,:]eas !re rema9 *all5g+ ob/acles to ! developm5t ( new treatm5ts = bra9 tumors1 & !re are no /rategies = scre5+ or e>ly detection ( bra9 tumors2 ,:]eas1 despite ! numb] ( p newly diagnos$ ) a bra9 tumor e ye>1 & _! deva/at+ prognoses1 !re h only be5 #d drugs & #a device approv$ by ! ,food & ,drug ,adm9i/ration to treat bra9 tumors dur+ ! prec$+ #cj ye>s2 ,:]eas ! mortality rates associat$ ) bra9 tumors h *ang$ little dur+ ! pa/ #cj ye>s2 ,:]eas !re is a ne$ = great] public aw>5ess ( bra9 tumors1 includ+ ! difficulties associat$ ) rese>* on ^? tumors & ! opportunities = advances 9 bra9 tumor rese>* & treatm5t2 & ,:]eas ,may #bjah1 :5 bra9 tumor advocates nationwide unite 9 aw>5ess1 outrea*1 & advocacy activities1 is an appropriate mon? to recognize z ,national ,bra9 ,tumor ,aw>5ess ,mon?3 ,n[1 !re=e1 be x ,t ! ,s5ate-- 7#a7 supports ! designation ( ,may #bjah z ,national ,bra9 ,tumor ,aw>5ess ,mon?2 7#b7 enc\rages increas$ public aw>5ess ( bra9 tumors to honor ^? :o h lo/ _! lives to t deva/at+ disease or are curr5tly liv+ ) a bra9 tumor diagnosis2 7#c7 supports ef=ts to develop bett] treatm5ts = bra9 tumors t w improve ! quality ( life & ! long-t]m prognosis ( ^? individuals diagnos$ ) a bra9 tumor2 7#d7 expresses its support = ^? individuals :o are battl+ bra9 tumors1 z well z ! families1 fri5ds1 & c>egiv]s ( ^? individuals2 & 7#e7 urges a collaborative approa* to bra9 tumor rese>*1 :i* is a promis+ means ( advanc+ und]/&+ (1 & treatm5t =1 bra9 tumors4